Miller JS

No ORCID on file · 5 papers in corpus · active 2018-2025
2025
Cell reports. Medicine ·doi:10.1016/j.xcrm.2025.102282

Human pluripotent stem cell (PSC) derivation advances have revealed enormous potential for improved cancer immunotherapy and clinical-scale blood cell production. PSCs can self-renew indefinitely and be differentiated into specialized cells…

2020
Metabolites ·doi:10.3390/metabo10040164

Central sensitization syndromes are a collection of frequently painful disorders that contribute to decreased quality of life and increased risk of opiate abuse. Although these disorders cause significant morbidity, they frequently lack rel…

2020
Molecules (Basel, Switzerland) ·doi:10.3390/molecules25204725

Vibrational spectroscopy (mid-infrared (IR) and Raman) and its fingerprinting capabilities offer rapid, high-throughput, and non-destructive analysis of a wide range of sample types producing a characteristic chemical "fingerprint" with a u…

2018
JCI insight ·doi:10.1172/jci.insight.96219

NK cell-based immunotherapies have been gaining traction in the clinic for treatment of cancer. IL-15 is currently being used in number of clinical trials to improve NK cell expansion and function. The objective of this study is to evaluate…

2018
Oncotarget ·doi:10.18632/oncotarget.26199

The demonstration that ovarian carcinoma (OC) is an immunogenic disease, opens opportunities to explore immunotherapeutic interventions to improve clinical outcome. In this regard, NK cell based immunotherapy could be promising as it has be…